IRIS Accounts Production v23.2.0.158 04049939 Board of Directors 1.7.22 30.6.23 30.6.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh040499392022-06-30040499392023-06-30040499392022-07-012023-06-30040499392021-06-30040499392021-07-012022-06-30040499392022-06-3004049939ns10:Originalns15:EnglandWales2022-07-012023-06-3004049939ns14:PoundSterlingns10:Original2022-07-012023-06-3004049939ns10:Originalns10:Director12022-07-012023-06-3004049939ns10:Original2022-07-012023-06-3004049939ns10:Original2023-06-3004049939ns10:Originalns10:PrivateLimitedCompanyLtd2022-07-012023-06-3004049939ns10:Originalns10:SmallEntities2022-07-012023-06-3004049939ns10:Originalns10:AuditExempt-NoAccountantsReport2022-07-012023-06-3004049939ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-07-012023-06-3004049939ns10:SmallCompaniesRegimeForAccountsns10:Original2022-07-012023-06-3004049939ns10:Originalns10:FullAccounts2022-07-012023-06-3004049939ns10:Original12022-07-012023-06-3004049939ns10:Originalns10:Director22022-07-012023-06-3004049939ns10:CompanySecretary1ns10:Original2022-07-012023-06-3004049939ns10:Originalns10:RegisteredOffice2022-07-012023-06-3004049939ns10:Original2022-06-3004049939ns10:Originalns5:CurrentFinancialInstruments2023-06-3004049939ns10:Originalns5:CurrentFinancialInstruments2022-06-3004049939ns5:ShareCapitalns10:Original2023-06-3004049939ns5:ShareCapitalns10:Original2022-06-3004049939ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-06-3004049939ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-06-3004049939ns5:IntangibleAssetsOtherThanGoodwillns10:Original2022-07-012023-06-3004049939ns10:Originalns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2022-07-012023-06-3004049939ns10:Originalns5:LeaseholdImprovements2022-07-012023-06-3004049939ns10:Originalns5:MotorVehicles2022-07-012023-06-3004049939ns10:Originalns5:ComputerEquipment2022-07-012023-06-3004049939ns10:Original2021-07-012022-06-3004049939ns5:IntangibleAssetsOtherThanGoodwillns10:Original2022-06-3004049939ns5:IntangibleAssetsOtherThanGoodwillns10:Original2023-06-3004049939ns5:IntangibleAssetsOtherThanGoodwillns10:Original2022-06-3004049939ns10:Originalns5:LeaseholdImprovements2022-06-3004049939ns10:Originalns5:PlantMachinery2022-06-3004049939ns10:Originalns5:MotorVehicles2022-06-3004049939ns10:Originalns5:ComputerEquipment2022-06-3004049939ns10:Original2022-06-3004049939ns10:Originalns5:PlantMachinery2022-07-012023-06-3004049939ns10:Originalns5:LeaseholdImprovements2023-06-3004049939ns10:Originalns5:PlantMachinery2023-06-3004049939ns10:Originalns5:MotorVehicles2023-06-3004049939ns10:Originalns5:ComputerEquipment2023-06-3004049939ns10:Originalns5:LeaseholdImprovements2022-06-3004049939ns10:Originalns5:PlantMachinery2022-06-3004049939ns10:Originalns5:MotorVehicles2022-06-3004049939ns10:Originalns5:ComputerEquipment2022-06-3004049939ns10:Originalns5:CostValuation2022-06-3004049939ns10:Originalns5:AdditionsToInvestments2023-06-3004049939ns10:Originalns5:CostValuation2023-06-3004049939ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-06-3004049939ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-06-30
REGISTERED NUMBER: 04049939 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 June 2023

for

Biomax Limited

Biomax Limited (Registered number: 04049939)

Contents of the Financial Statements
for the Year Ended 30 June 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Biomax Limited

Company Information
for the Year Ended 30 June 2023







DIRECTORS: R P Smith
J M Shambrook





SECRETARY: J M Shambrook





REGISTERED OFFICE: Beck Cottage
Main Street
Elvington
York
YO41 4AG





REGISTERED NUMBER: 04049939 (England and Wales)





ACCOUNTANTS: Harris Lacey and Swain
Suite 1
The Riverside Building
Hessle
East Yorkshire
HU13 0DZ

Biomax Limited (Registered number: 04049939)

Balance Sheet
30 June 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 10,537 10,537
Tangible assets 5 100,610 100,698
Investments 6 395,285 165,724
506,432 276,959

CURRENT ASSETS
Stocks 106,694 161,281
Debtors 7 872,276 951,009
Cash at bank 702,487 725,196
1,681,457 1,837,486
CREDITORS
Amounts falling due within one year 8 201,534 255,072
NET CURRENT ASSETS 1,479,923 1,582,414
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,986,355

1,859,373

PROVISIONS FOR LIABILITIES 2,316 1,777
NET ASSETS 1,984,039 1,857,596

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 1,984,037 1,857,594
SHAREHOLDERS' FUNDS 1,984,039 1,857,596

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Biomax Limited (Registered number: 04049939)

Balance Sheet - continued
30 June 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 2 October 2023 and were signed on its behalf by:





J M Shambrook - Director


Biomax Limited (Registered number: 04049939)

Notes to the Financial Statements
for the Year Ended 30 June 2023


1. STATUTORY INFORMATION

Biomax Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Although these estimates are based on the Directors' best knowledge of the amount, events or actions, actual results ultimately differ from these estimates. The Directors do not consider there to be any material estimates and judgements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development Costs are being amortised evenly over their estimated useful life of nil years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - Not depreciated
Motor vehicles - 25% on reducing balance
Computer equipment - 33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
The company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments, including trade and other debtors and creditors are initially recognised at transaction value and subsequently measure at their settlement value.

Research and development
Expenditure on research and development is capitalised to the extent that it is considered to have ongoing value by the directors

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2022 - 2 ) .

Biomax Limited (Registered number: 04049939)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2023


4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 July 2022
and 30 June 2023 10,537
NET BOOK VALUE
At 30 June 2023 10,537
At 30 June 2022 10,537

5. TANGIBLE FIXED ASSETS
Improvements
to Plant and Motor Computer
property machinery vehicles equipment Totals
£    £    £    £    £   
COST
At 1 July 2022 91,348 2,150 34,996 11,408 139,902
Additions - 287 - 5,126 5,413
At 30 June 2023 91,348 2,437 34,996 16,534 145,315
DEPRECIATION
At 1 July 2022 - 2,150 28,768 8,286 39,204
Charge for year - 71 1,557 3,873 5,501
At 30 June 2023 - 2,221 30,325 12,159 44,705
NET BOOK VALUE
At 30 June 2023 91,348 216 4,671 4,375 100,610
At 30 June 2022 91,348 - 6,228 3,122 100,698

Biomax Limited (Registered number: 04049939)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2023


6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 July 2022 165,724
Additions 229,561
At 30 June 2023 395,285
NET BOOK VALUE
At 30 June 2023 395,285
At 30 June 2022 165,724

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 97,112 130,577
Other debtors 775,164 820,432
872,276 951,009

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 72,696 96,427
Taxation and social security 124,502 154,451
Other creditors 4,336 4,194
201,534 255,072

9. RELATED PARTY DISCLOSURES

Included in other debtors is an inter-company balance of £769,201 owed by Maryhill Limited, a company owned and controlled by both directors.